Cognition Therapeutics Presents Preclinical Data On Zervimesine, Stock Down
9/5 17:46
(RTTNews) - Cognition Therapeutics Inc (CGTX) Friday unveiled preclinical findings at the ARVO conference demonstrating that its oral candidate zervimesine protects retinal pigment epithelial cells in dry age-related macular degeneration....